Skip to main content
. 2019 May 27;9:7858. doi: 10.1038/s41598-019-44140-3

Table 2.

The cerebral adrenoleukodystrophy neurologic function score (NFS) used to evaluate gross clinical neurologic status for the cALD cohort pre-transplantation.

Neurologic Function Score Points
Hearing/auditory processing problems 1
Aphasia/apraxia 1
Loss of communication 3
Vision impairment/fields cut 1
Cortical blindness 2
Swallowing difficulty or other central nervous system dysfunction 2
Tube feeding 2
Running difficulties/hyperreflexia 1
Walking difficulties/spasticity/spastic gait (no assistance) 1
Spastic gait (needs assistance) 2
Wheelchair required 2
No voluntary movement 3
Episodes of incontinency 1
Total incontinency 2
Nonfebrile seizures 1
25 total

Note that a score of zero denotes absence of clinical signs of cerebral disease. Maximal signs within a domain score the total of all grades within that domain (for example, a patient with “total urinary or fecal incontinency” scores 3, for the sum of “Episodes of incontinency” [1 point] and “Total Incontinency” [2 additional points]).